Morningstar

OutSee Completes Seed Funding Round and Establishes Partnership With o2h Discovery for Lead Drug Target Candidate

Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme OutSee, a genomics and drug discovery company pioneering a unique ...
technologynetworks

PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery Programs

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal ...
PharmiWeb

Fast Custom Peptide Synthesis Services for Drug Discovery: Why It Matters and How the o2h Peptide Guarantee Delivers

Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction ...
PR Newswire

O2h Discovery: Chemistry in the Cloud™ - The World's First App To Project Manage Drug Discovery

CAMBRIDGE, England, Nov. 1, 2017 /PRNewswire/ -- O2h Discovery announced the worldwide launch of their revolutionary new project management app – Chemistry in the Cloud™ on 10 th September 2017 at ...
PharmiWeb

Introducing the o2h Peptide Guarantee: Get peptide delivered in 2 weeks. If delayed, it's on us.

Timely access to high-quality peptides is essential in drug discovery, especially for screening, structure-activity relationship (SAR) studies, and early-stage preclinical research. Any delay in ...
Yahoo Finance

OutSee Completes Seed Funding Round and Establishes Partnership With o2h Discovery for Lead Drug Target Candidate

CAMBRIDGE, England, January 12, 2026--(BUSINESS WIRE)--OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the ...
News Medical

OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...